For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
日本語
简体中文
Menu
For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
日本語
简体中文
For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
日本語
简体中文
For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
日本語
简体中文
Icon-twitter-x
Facebook-f
News
All
Press
Media
Events
Other
[Summary of Research]The University of Arizona developed a human iPS cell-derived cardiomyocyte patch for the treatment of heart failure (Published in 2019)
•
March 12, 2021
•
Other
[Summary of Research]Kyoto University has generated iPS cells with less risk of rejection by genome editing
•
March 2, 2021
•
Other
I Peace CEO Tanabe pressents at RINK FESTIVAL 2021
•
February 25, 2021
•
Events
[Summary of Research]Kyoto University has succeeded in regenerating T-cells from human iPS cells that enhance effects of cancer immunotherapy(2018)
•
February 22, 2021
•
Other
[Summary of research available] Kyoto University developed a scalable method to regenerate T-cells from iPSCs
•
February 5, 2021
•
Other
Renewal of I Peace website
•
February 5, 2021
•
Other
I Peace in the News – the NIKKAN KOGYO SHIMBUN December 28, 2020
•
January 10, 2021
•
Media
I Peace, Inc. and Avery Therapeutics announce collaboration to bring iPSC derived cell therapy for heart failure to the clinic
•
December 29, 2020
•
Press
I Peace, Inc. obtains IRB Approval for Production of Clinical and Research-Grade iPSCs for Commercial Use
•
December 4, 2020
•
Press
I Peace CEO Koji Tanabe to Present at 2020 Virtual Cell & Gene Meeting on the Mesa
•
October 7, 2020
•
Events
Reach out to us to learn more
Contact Us